AN IMPROVED MODEL FOR PREDICTING RADIATION PNEUMONITIS INCORPORATING CLINICAL AND DOSIMETRIC VARIABLES

被引:97
作者
Jenkins, Peter [1 ]
Watts, Joanne [1 ]
机构
[1] Cheltenham Gen Hosp, Gloucestershire Oncol Ctr, Cheltenham GL53 7AN, Glos, England
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2011年 / 80卷 / 04期
关键词
Lung cancer; Radiation pneumonitis; Dose-volume histogram; Angiotensin converting enzyme inhibitor; CELL LUNG-CANCER; VOLUME HISTOGRAM ANALYSIS; CONVERTING ENZYME-INHIBITORS; RADIOTHERAPY; TOXICITY; CHEMOTHERAPY; IRRADIATION; TGF-BETA-1; THERAPY; INJURY;
D O I
10.1016/j.ijrobp.2010.03.058
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Purpose: Single dose volume metrics are of limited value for the prediction of radiation pneumonitis (RP) in day-to-day clinical practice. We investigated whether multiparametric models that incorporate clinical and physiologic factors might have improved accuracy. Methods and Materials: The records of 160 patients who received radiation therapy for non small-cell lung cancer were reviewed. All patients were treated to the same dose and with an identical technique. Dosimetric, pulmonary function, and clinical parameters were analyzed to determine their ability to predict for the subsequent development of RP. Results: Twenty-seven patients (17%) developed RP. On univariate analysis, the following factors were significantly correlated with the risk of pneumonitis: fractional volume of lung receiving >5-20 Gy, absolute volume of lung spared from receiving >5-15 Gy, mean lung dose, craniocaudal position of the isocenter, transfer coefficient for carbon monoxide (KCOc), total lung capacity, coadministration of angiotensin converting enzyme inhibitors, and coadministration of angiotensin receptor antagonists. By combining the absolute volume of lung spared from receiving >5 Gy with the KCOc, we defined a new parameter termed Transfer Factor Spared from receiving >5 Gy (TIFS(5)). The area under the receiver operator characteristic curve for TFS(5) was 0.778, increasing to 0.846 if patients receiving modulators of the renin-angiotensin system were excluded from the analysis. Patients with a TFS(5) <2.17 mmol/min/kPa had a risk of RP of 30% compared with 5% for the group with a TFS(5) >= 2.17. Conclusions: TFS5 represents a simple parameter that can be used in routine clinical practice to more accurately segregate patients into high- and low-risk groups for developing RP. (C) 2011 Elsevier Inc.
引用
收藏
页码:1023 / 1029
页数:7
相关论文
共 33 条
[1]
Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma [J].
Allen, AM ;
Czerminska, M ;
Jänne, PA ;
Sugarbaker, DJ ;
Bueno, R ;
Harris, JR ;
Court, L ;
Baldini, EH .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 65 (03) :640-645
[2]
A nomogram to predict radiation pneumonitis, derived from a combined analysis of rtog 9311 and institutional data [J].
Bradley, Jeffrey D. ;
Hope, Andrew ;
El Naqa, Issam ;
Apte, Aditya ;
Lindsay, Patricia E. ;
Bosch, Walter ;
Matthews, John ;
Sause, Wrlliam ;
Graham, Mary V. ;
Deasy, Joseph O. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (04) :985-992
[3]
Predicting lung radiotherapy-induced pneumonitis using a model combining parametric lyman probit with nonparametric decision trees [J].
Das, Shiva K. ;
Zhou, Sumin ;
Zhang, Junan ;
Yin, Fang-Fang ;
Dewhirst, Mark W. ;
Marks, Lawrence B. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 68 (04) :1212-1221
[4]
The importance of patient characteristics for the prediction of radiation-induced lung toxicity [J].
Dehing-Oberije, Cary ;
De Ruysscher, Dirk ;
van Baardwijk, Angela ;
Yu, Shipeng ;
Rao, Bharat ;
Lambin, Philippe .
RADIOTHERAPY AND ONCOLOGY, 2009, 91 (03) :421-426
[5]
TOLERANCE OF NORMAL TISSUE TO THERAPEUTIC IRRADIATION [J].
EMAMI, B ;
LYMAN, J ;
BROWN, A ;
COIA, L ;
GOITEIN, M ;
MUNZENRIDER, JE ;
SHANK, B ;
SOLIN, LJ ;
WESSON, M .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1991, 21 (01) :109-122
[6]
Dose-volume histogram analysis as predictor of radiation pneumonitis in primary lung cancer patients treated with radiotherapy [J].
Fay, M ;
Tan, A ;
Fisher, R ;
Mac Manus, M ;
Wirth, A ;
Ball, D .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 61 (05) :1355-1363
[7]
The relationship between local dose and loss of function for irradiated lung [J].
Gopal, R ;
Tucker, SL ;
Komaki, R ;
Liao, ZX ;
Forster, KM ;
Stevens, C ;
Kelly, JF ;
Starkschall, G .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 56 (01) :106-113
[8]
Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC) [J].
Graham, MV ;
Purdy, JA ;
Emami, B ;
Harms, W ;
Bosch, W ;
Lockett, MA ;
Perez, CA .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 45 (02) :323-329
[9]
SOUTHWEST-ONCOLOGY-GROUP STANDARD RESPONSE CRITERIA, END-POINT DEFINITIONS AND TOXICITY CRITERIA [J].
GREEN, S ;
WEISS, GR .
INVESTIGATIONAL NEW DRUGS, 1992, 10 (04) :239-253
[10]
Radiation-induced pulmonary toxicity: A dose-volume histogram analysis in 201 patients with lung cancer [J].
Hernando, ML ;
Marks, LB ;
Bentel, GC ;
Zhou, SM ;
Hollis, D ;
Das, SK ;
Fan, M ;
Munley, MT ;
Shafman, TD ;
Anscher, MS ;
Lind, PA .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 51 (03) :650-659